Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BELAFENDO
2024-515577-10-00Phase 4Authorised
- Sponsor
- Rouen University Hospital
- Start
- Oct 2024
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of belatacept in Kidney allograft status (RTx) (2 arms), sponsored by Rouen University Hospital. Planned start Oct 2024; status: authorised.
02
Drugs
belatacept
03
Conditions
Kidney allograft status (RTx)
Beyond the preview
Go deeper on 2024-515577-10-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515577-10-00.